Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular diagnostics leader, announces that the Company has showcased its leading-edge microarray technology at the 22 nd Annual International Plant and Animal Genome Conference (PAG XXII) in San Diego, California, held on January 11-15, 2014. PAG XXII, the largest agricultural genomics meeting in the world, features more than 3,200 scientists, 130 exhibits, 150 workshops, 1,000 posters and 1,800 abstracts. Plant and animal genomics focuses on research and product development based on the DNA sequence genetic blueprints of crop plants, botanical species, livestock, and bacterial and viral pathogens that can compromise food quality and safety.
Arrayit presented the Company’s leading-edge, patented and proprietary microarray products and services and hosted a technology workshop entitled “Breakthroughs in Microarray Technology” that included luminary speakers, guest scientist appearances and attendee raffles.
Mark Schena, President of Arrayit Corporation, commented, “The PAG XXII conference was very successful for us, resulting in a record number of sales leads and providing an effective forum to present our innovative technology and solutions to the industry. We are thrilled about the positive reception and look forward to building on the many relationships we developed.”
About Arrayit CorporationArrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™ Visit http://arrayit.com/ for more information. Safe Harbor Statement We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for the quarterly period ended September 30, 2013.